Erg Bio Secures $6.5M Seed Funding to Scale Biomass-to-Fuel and Bio-Based Chemical Technology
Erg Bio, a California‑based biotechnology company developing advanced biomass valorization technology to produce synthetic aviation fuels and critical bio‑based chemicals, announced the successful close of a $6.5 million seed funding round aimed at scaling its proprietary Aspire™ Technology platform. The financing will support the company’s efforts to convert agricultural and forestry residues and other biomass waste into cost‑competitive fuel and chemical intermediates, strengthening domestic supply chains and advancing cleaner manufacturing processes.
The seed round was led by Azolla Ventures, a venture capital firm focused on supporting early‑stage climate and energy tech companies with transformative solutions. Joining Azolla in this round were strategic partners including Chevron Technology Ventures, the corporate venture arm of Chevron that invests in technologies advancing energy innovation; Freeflow; Plug and Play Tech Center, a global innovation platform that connects startups with corporate partners; and a group of strategic angel investors who bring experience and insight from across biotech and industrial sectors.
Erg Bio’s Aspire™ Technology is designed as a flexible, low‑temperature pretreatment and catalytic process that can handle a wide variety of biomass feedstocks — including more than 30 types of agricultural and forestry residues — to produce affordable intermediates for sustainable aviation fuel and other biochemicals. This flexibility addresses a key limitation in traditional biomass conversion methods, which often struggle with mixed or non‑standard feedstocks. By broadening the range of usable raw materials, Erg Bio’s platform enhances supply‑chain resilience and supports regional economic development by turning underutilized biomass into high‑value products.
With this new funding, Erg Bio plans to advance its technical validation efforts and move toward pilot‑scale demonstrations of its technology, a significant step toward commercial deployment. Company leadership has emphasized that scaling these demonstrations will help accelerate progress toward larger‑scale facilities capable of producing intermediates for synthetic fuels and other bio‑based products at industrial volumes.
Erg Bio co‑founder and CEO Vineet Rajgarhia highlighted the transformative potential of the company’s approach, noting that the investment enables further development of a process that could reshape traditional bioindustrial manufacturing by unlocking the value of abundant biomass waste. The Aspire™ Technology platform originated from foundational research at the Lawrence Berkeley National Laboratory’s Joint BioEnergy Institute before being commercialized by Erg Bio, and it reflects years of innovation aimed at overcoming longstanding hurdles in biomass conversion.
The seed funding round also reflects broader interest in sustainable and resilient bioeconomy solutions as the United States and other nations prioritize energy security and diversification of industrial feedstocks. By converting waste biomass into valuable intermediates for fuels and chemicals, Erg Bio is positioned at the intersection of industrial decarbonization and resource efficiency, offering tools that could support both rural economies and broader energy policy goals.
Investor perspectives on Erg Bio’s platform underscored confidence in the technology’s ability to address bottlenecks in current biomass processing technologies. Amy Duffuor, General Partner and Co‑Founder of Azolla Ventures, described Erg Bio’s manufacturing platform as a systems‑level innovation with the potential to reshape supply chains for synthetic fuels and chemicals. Jim Gable, President of Chevron Technology Ventures, noted that Erg Bio’s approach tackles historical challenges in cellulosic ethanol production, suggesting a pathway to opening up substantial untapped market opportunities.
Erg Bio’s leadership team combines deep expertise in biotechnology, energy, and industrial processes, enabling the company to translate cutting‑edge research into viable industrial applications. With this fresh infusion of capital, the startup expects to expand its engineering and bioprocessing teams to support ongoing development and commercialization efforts.
Going forward, Erg Bio aims to demonstrate its technology’s commercial viability through pilot operations, attract offtake agreements with potential customers in aviation fuels and specialty chemical markets, and further strengthen its position within the emerging bioindustrial sector. The successful seed round marks a critical milestone in the company’s growth trajectory and reflects growing investor interest in sustainable alternatives to conventional fossil‑based manufacturing inputs.
Overall, the funding will enable Erg Bio to accelerate its mission to turn overlooked biomass resources into cost‑competitive, environmentally beneficial products that support the transition to a more resilient and sustainable industrial economy.
